BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen LK, Arai H, Chen LY, Chou MY, Djauzi S, Dong B, Kojima T, Kwon KT, Leong HN, Leung EM, Liang CK, Liu X, Mathai D, Pan JY, Peng LN, Poblete ER, Poi PJ, Reid S, Tantawichien T, Won CW. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis 2017;17:213. [PMID: 28298208 DOI: 10.1186/s12879-017-2198-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Kang DH, Kwak BO, Park AY, Kim HW. Clinical Manifestations of Herpes Zoster Associated with Complications in Children. Children (Basel) 2021;8:845. [PMID: 34682110 DOI: 10.3390/children8100845] [Reference Citation Analysis]
2 Nayak MK, Kapadia JD, Desai CK, Desai MK, Shah BJ. An Evaluation of Efficacy and Safety of Commonly Prescribed Drugs and Effect of These Drugs on Quality of Sleep in Patients Suffering From Zoster-Associated Pain. J Clin Pharmacol 2018;58:1406-17. [PMID: 29799622 DOI: 10.1002/jcph.1255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yang F, Yu S, Fan B, Liu Y, Chen YX, Kudel I, Concialdi K, DiBonaventura M, Hopps M, Hlavacek P, Cappelleri JC, Sadosky A, Parsons B, Udall M. The Epidemiology of Herpes Zoster and Postherpetic Neuralgia in China: Results from a Cross-Sectional Study. Pain Ther 2019;8:249-59. [PMID: 31218562 DOI: 10.1007/s40122-019-0127-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ahmad MF, Ahmad FA, Khan MI, Alsayegh AA, Wahab S, Alam MI, Ahmed F. Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties. Int J Biol Macromol 2021;187:769-79. [PMID: 34197853 DOI: 10.1016/j.ijbiomac.2021.06.122] [Reference Citation Analysis]
5 Kim JH, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, Hastie A, Hui DSC, Irimajiri J, Lee J, Leung EM, Tang H, Tsuru T, Watson P, Wu Z, Yu CJ, Yuan Y, Zahaf T, Cunningham AL, Schuind A. The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Hum Vaccin Immunother 2021;17:2050-7. [PMID: 33606577 DOI: 10.1080/21645515.2020.1859321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Patki A, Vora A, Parikh R, Kolhapure S, Agrawal A, Dash R. Herpes zoster in outpatient departments of healthcare centers in India: a review of literature. Hum Vaccin Immunother 2021;:1-8. [PMID: 34520327 DOI: 10.1080/21645515.2021.1968737] [Reference Citation Analysis]
7 Shrestha M, Chen A. Modalities in managing postherpetic neuralgia. Korean J Pain 2018;31:235-43. [PMID: 30310548 DOI: 10.3344/kjp.2018.31.4.235] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
8 Ryu HJ, Han JO, Lee SA, Seo MR, Choi HJ, Ko KP, Baek HJ. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea. Rheumatology (Oxford) 2021;60:2427-33. [PMID: 33232486 DOI: 10.1093/rheumatology/keaa636] [Reference Citation Analysis]
9 Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, Ren Y, He Y, Feng Y. A systematic literature review to assess the burden of herpes zoster disease in China. Expert Rev Anti Infect Ther 2021;19:165-79. [PMID: 32997550 DOI: 10.1080/14787210.2020.1792290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Radosavljevic A, Agarwal M, Chee SP, Zierhut M. Epidemiology of Viral Induced Anterior Uveitis. Ocul Immunol Inflamm 2021;:1-13. [PMID: 33617392 DOI: 10.1080/09273948.2020.1853177] [Reference Citation Analysis]
11 Choi JK, Park SH, Park S, Cho SY, Lee HJ, Kim SH, Choi SM, Lee DG, Choi JH, Yoo JH. The changing epidemiology of herpes zoster over a decade in South Korea, 2006-2015. Vaccine 2019;37:5153-60. [PMID: 31377077 DOI: 10.1016/j.vaccine.2019.07.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Bolton LL, Faller N, Kirsner RS. Herpes Zoster (Shingles) Patient-Centered Wound Outcomes: A Literature Review. Adv Skin Wound Care 2021;34:239-48. [PMID: 33852460 DOI: 10.1097/01.ASW.0000737412.71091.4f] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Schutzer-Weissmann J, Farquhar-Smith P. Post-herpetic neuralgia - a review of current management and future directions. Expert Opin Pharmacother 2017;18:1739-50. [PMID: 29025327 DOI: 10.1080/14656566.2017.1392508] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
14 Mbinta JF, Nguyen BP, Awuni PMA, Eme PE, Simpson CR. Postlicensure herpes zoster vaccine effectiveness: systematic review protocol. BMJ Open 2021;11:e040964. [PMID: 33622942 DOI: 10.1136/bmjopen-2020-040964] [Reference Citation Analysis]
15 Goh AEN, Choi EH, Chokephaibulkit K, Choudhury J, Kuter B, Lee PI, Marshall H, Kim JO, Wolfson LJ. Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Rev Vaccines 2019;18:475-93. [PMID: 30869552 DOI: 10.1080/14760584.2019.1594781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
16 Teresa Aguado M, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, Hyde TB, Jit M, Jones R, Poland GA, Friede M, Ortiz JR. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. Vaccine 2018;36:921-31. [PMID: 29336923 DOI: 10.1016/j.vaccine.2017.12.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
17 Gao HX, Zhang JJ, Liu N, Wang Y, Ma CX, Gao LL, Liu Q, Zhang TT, Wang YL, Bao WQ, Li YX. A fixed nitrous oxide/oxygen mixture as an analgesic for patients with postherpetic neuralgia: study protocol for a randomized controlled trial. Trials 2021;22:29. [PMID: 33407845 DOI: 10.1186/s13063-020-04960-5] [Reference Citation Analysis]
18 Zhang Z, Deng W, Wu Q, Sun L. Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis. Immunotherapy 2019;11:321-33. [DOI: 10.2217/imt-2018-0113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
19 Álvaro-Gracia JM, García-Llorente JF, Valderrama M, Gomez S, Montoro M. Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review. Rheumatol Ther 2021;8:17-40. [PMID: 33245555 DOI: 10.1007/s40744-020-00258-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Fukuchi K, Shimauchi T, Tatsuno K, Tokura Y. Induction of plasmablasts by follicular helper T cell-CXCL13 axis upon occurrence of herpes zoster. Clin Immunol 2018;195:93-100. [PMID: 30118865 DOI: 10.1016/j.clim.2018.08.003] [Reference Citation Analysis]
21 Mufti M, Shackles C, Alvi E, Nath J. Herpes zoster ophthalmicus caught in the (Tr)act! Emerg Radiol 2018;25:557-9. [PMID: 29987527 DOI: 10.1007/s10140-018-1622-y] [Reference Citation Analysis]
22 Nam KH, Jung ES, Park J, Yun SK. A clinical and etiologic study of herpes zoster multiplex. J Am Acad Dermatol 2021;85:1010-1. [PMID: 33065171 DOI: 10.1016/j.jaad.2020.10.011] [Reference Citation Analysis]
23 Udayachalerm S, Renouard MG, Anothaisintawee T, Thakkinstian A, Veettil SK, Chaiyakunapruk N. Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence. J Med Econ 2022;25:26-37. [PMID: 34791974 DOI: 10.1080/13696998.2021.2008195] [Reference Citation Analysis]
24 Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother 2019;15:645-57. [PMID: 30427766 DOI: 10.1080/21645515.2018.1546525] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]